I make a donation
objectif
International multicentric trial aiming to compare, over 2 months, the effect of a treatment with irbesartan to a treatment with enalapril on cardio-vascular markers in patients with acute coronary syndrome without ST segment elevation.
date de réalisation
2006
nombre de patients
429
nombre de centres participants
63 centers in 11 countries
type de financement
Private (Sanofi-Aventis et BMS)
Référence
NCT00296218
Randomized Comparison of a Two-month Regimen of Irbesartan Versus Enalapril on Cardiovascular Markers in Patients With Acute Coronary Syndrome Without ST Segment Elevation (ARCHIPELAGO)
The main objective of this study is to assess if a two-month regimen of irbesartan in patients hospitalized for acute coronary syndrome without ST segment elevation can reduce inflammation markers (ie hsCRP), in comparison to a similar regimen of enalapril.
source clinicaltrials.gov
Publications
En cours
En cours
En cours